About ZAXOL Injection 30
Spotlight ZAXOL Injection 30 as an inestimable choice in the realm of cytotoxic injectables. Expertly crafted for intravenous infusion, this prescription-only solution is renowned for its radiant efficacy against advanced and metastatic cancers, such as breast, lung, prostate, gastric, and head & neck cancer. Each glass vial offers a special concentration of 30 mg/0.5 ml Docetaxel Trihydrate, accompanied by a dedicated solvent for optimal use. Imported with noteworthy standards, ZAXOL Injection 30s clear yellowish solution ensures precision in hospital and clinical settings. Handle with care due to its cytotoxic nature. MSDS available.
Usage Type, Advantage, and Application Method
ZAXOL Injection 30 is designated for professional use within hospitals and clinical environments due to its potent cytotoxic formulation. Its single-use vial with provided solvent simplifies the preparation process, ensuring safe handling. The advantage of intravenous administration means streamlined delivery directly to the bloodstream for rapid anti-cancer effects. Recommended strictly for prescription use, ZAXOL Injection 30 is ideally suited for targeted chemotherapy regimens in advanced stages of several cancer types.
Main Domestic Market, Certifications, and Delivery Time
Catering predominantly to the Indian market, ZAXOL Injection 30 is distributed through a prominent network of dealers, suppliers, wholesalers, and traders. Each shipment is meticulously processed following a confirmed purchase order, with certified packaging standards and detailed product inserts included. Timely goods transport ensures swift delivery, typically within 2-3 days post order confirmation. Certifications and MSDS documentation are provided to meet stringent hospital and clinical requirements.
FAQs of ZAXOL Injection 30:
Q: How is ZAXOL Injection 30 prepared and administered?
A: ZAXOL Injection 30 comes in a glass vial with a provided solvent for reconstitution. After mixing according to instructions, the medication is administered intravenously by a qualified healthcare professional in a hospital or clinical setting.
Q: What is the primary benefit of using ZAXOL Injection 30 in cancer treatment?
A: The primary benefit of ZAXOL Injection 30 is its effectiveness as an anti-cancer chemotherapy agent for advanced or metastatic cancers, including breast, lung, prostate, gastric, and head & neck cancers.
Q: When should ZAXOL Injection 30 be used, and is a prescription necessary?
A: ZAXOL Injection 30 should only be used when prescribed by a qualified physician for the indicated cancers. It is mandatory to have a valid prescription due to its cytotoxic properties and specific handling requirements.
Q: Where is ZAXOL Injection 30 sourced and who distributes it?
A: ZAXOL Injection 30 is an imported product, distributed within India by licensed dealers, distributors, exporters, importers, and suppliers, ensuring broad accessibility in clinical and hospital pharmacies.
Q: What special precautions must be taken during the process of handling ZAXOL Injection 30?
A: As a cytotoxic agent, ZAXOL Injection 30 must be handled with extreme care by healthcare professionals. Personal protective equipment and safety protocols should always be followed to prevent potential exposure.
Q: What is the shelf life and storage instruction for ZAXOL Injection 30?
A: ZAXOL Injection 30 has a shelf life of 2-3 years and requires normal storage conditions as specified in the product insert. Always check the vial and packaging for any signs of damage or expiry before use.